GB9716460D0 - In vivo assay - Google Patents

In vivo assay

Info

Publication number
GB9716460D0
GB9716460D0 GBGB9716460.2A GB9716460A GB9716460D0 GB 9716460 D0 GB9716460 D0 GB 9716460D0 GB 9716460 A GB9716460 A GB 9716460A GB 9716460 D0 GB9716460 D0 GB 9716460D0
Authority
GB
United Kingdom
Prior art keywords
vivo assay
vivo
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9716460.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB9716460.2A priority Critical patent/GB9716460D0/en
Priority to DE69736390T priority patent/DE69736390T2/en
Priority to AU45673/97A priority patent/AU726745B2/en
Priority to EP97944028A priority patent/EP0929303B1/en
Priority to ES97944028T priority patent/ES2267153T3/en
Priority to AT97944028T priority patent/ATE333879T1/en
Priority to PCT/GB1997/002748 priority patent/WO1998015277A2/en
Priority to CA002266773A priority patent/CA2266773A1/en
Priority to JP10517306A priority patent/JP2001502311A/en
Publication of GB9716460D0 publication Critical patent/GB9716460D0/en
Priority to US08/994,063 priority patent/US6117855A/en
Priority to US09/457,241 priority patent/US6319953B1/en
Priority to US09/978,437 priority patent/US6649614B2/en
Pending legal-status Critical Current

Links

GBGB9716460.2A 1996-10-07 1997-08-04 In vivo assay Pending GB9716460D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB9716460.2A GB9716460D0 (en) 1997-08-04 1997-08-04 In vivo assay
AT97944028T ATE333879T1 (en) 1996-10-07 1997-10-07 CNS-PENETRATING NK-1 RECEPTOR ANTAGONISTS AS AN ANTIDEPRESSANT AND/OR ANXIOLYTIC
AU45673/97A AU726745B2 (en) 1996-10-07 1997-10-07 CNS-penetrant NK-1 receptor antagonists as antidepressant and/or an anti-anxiety agent
EP97944028A EP0929303B1 (en) 1996-10-07 1997-10-07 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent
ES97944028T ES2267153T3 (en) 1996-10-07 1997-10-07 NK-1 RECEPTOR ANTAGONISTS OF THE CNS AS ANTIDEPRESSIVE AGENTS AND / OR ANTIANSIEDAD.
DE69736390T DE69736390T2 (en) 1996-10-07 1997-10-07 CNS PENETRATING NK-1 RECEPTOR ANTAGONISTS AS ANTIDEPRESSIVE AND / OR ANXIOLYTIC
PCT/GB1997/002748 WO1998015277A2 (en) 1996-10-07 1997-10-07 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents
CA002266773A CA2266773A1 (en) 1996-10-07 1997-10-07 Use of a nk-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
JP10517306A JP2001502311A (en) 1996-10-07 1997-10-07 CNS permeable NK-1 receptor antagonist as antidepressant and / or anxiolytic
US08/994,063 US6117855A (en) 1996-10-07 1997-12-19 Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
US09/457,241 US6319953B1 (en) 1996-10-07 1999-12-08 Treatment of depression and anxiety with fluoxetine and an NK-1 receptor antagonist
US09/978,437 US6649614B2 (en) 1996-10-07 2001-10-16 Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent for treatment of depression or anxiety

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9716460.2A GB9716460D0 (en) 1997-08-04 1997-08-04 In vivo assay

Publications (1)

Publication Number Publication Date
GB9716460D0 true GB9716460D0 (en) 1997-10-08

Family

ID=10816949

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9716460.2A Pending GB9716460D0 (en) 1996-10-07 1997-08-04 In vivo assay

Country Status (1)

Country Link
GB (1) GB9716460D0 (en)

Similar Documents

Publication Publication Date Title
DE69834346D1 (en) Proteinexpression in baculovirus-vektor expressionsystemen
GB9719044D0 (en) Assay
IL131867A0 (en) Anti-epileptogenic agents
GB2320435B (en) Improvements in Magnotherapy
GB9903309D0 (en) Probe card
GB9700805D0 (en) Improvements in confectionery
GB9715034D0 (en) Assay
GB9708240D0 (en) Improvements in or relating to contrast agents
GB9702252D0 (en) Collagen assay
GB9717588D0 (en) Improvements in or relating to contrast agents
GB9718712D0 (en) Theraputic Agents
GB9717589D0 (en) Improvements in or relating to contrast agents
GB9701237D0 (en) Improvements in or relating to contrast agents
GB9721240D0 (en) Assay
PL339259A1 (en) Gonadothropin expression in dictostelium
GB9803156D0 (en) Assay
GB9704162D0 (en) Assay methods and means
GB9727277D0 (en) Assay
GB2341808B (en) Improvements in yo-yos
GB9716458D0 (en) In vivo assay
GB9716460D0 (en) In vivo assay
GB9704312D0 (en) Diagnostic assay
GB9719428D0 (en) Assay
GB9707141D0 (en) Biological assay
GB9719809D0 (en) Assay